• 1. Excellent energy storage performance in NaNbO3-based relaxor antiferroeic ceramics under a low electric field
  XuxinCheng,XiaomingChen,PengyuanFan
• 2. Excellent kinetics of single-phase Gd-doped ceria fuel electrodes in solid oxide cells?
  Andreas Nenning,Manuel Holzmann,Jürgen Fleig,Alexander K. Opitz Mater. Adv., 2021,2, 5422-5431
• 3. Evidence of field induced slow magnetic relaxation in cis-[Co(hfac)2(H2O)2] exhibiting tri-axial anisotropy with a negative axial component?
  Denis V. Korchagin,Elena A. Yureva,Alexander V. Akimov,Eugenii Ya. Misochko,Gennady V. Shilov,Artem D. Talantsev,Roman B. Morgunov,Alexander A. Shakin,Sergey M. Aldoshin,Boris S. Tsukerblat Dalton Trans., 2017,46, 7540-7548
• 4. Enabling stable MnO2 matrix for aqueous zinc-ion battery cathodes?
  Yiding Jiao,Liqun Kang,Jasper Berry-Gair,Kit McColl,Jianwei Li,Haobo Dong,Hao Jiang,Ryan Wang,Furio Corà,Dan J. L. Brett,Ivan P. Parkin J. Mater. Chem. A, 2020,8, 22075-22082
• 5. Embedding heteroatoms: an effective approach to create porphyrin-based functional materials
  Norihito Fukui,Keisuke Fujimoto,Hideki Yorimitsu,Atsuhiro Osuka Dalton Trans., 2017,46, 13322-13341

Deloxolone (CAS No. 68635-50-7): A Comprehensive Overview of Its Properties and Applications

Deloxolone (CAS No. 68635-50-7) is a synthetic compound that has garnered significant attention in recent years due to its potential therapeutic and industrial applications. This article delves into the chemical properties, mechanisms of action, and current research trends surrounding Deloxolone, while also addressing common queries and emerging topics in the field.

The chemical structure of Deloxolone is characterized by its unique steroidal framework, which contributes to its biological activity. Researchers have identified its potential as an anti-inflammatory agent, making it a subject of interest in the development of new pharmaceuticals. The compound's CAS number 68635-50-7 is frequently searched in academic databases, reflecting its growing relevance in scientific literature.

One of the most discussed aspects of Deloxolone is its potential role in addressing chronic inflammatory conditions. With the rise in autoimmune diseases and inflammatory disorders, the demand for novel therapeutic agents has never been higher. Deloxolone has shown promise in preclinical studies, particularly in modulating immune responses and reducing oxidative stress. These findings align with current trends in personalized medicine and targeted therapies.

In addition to its pharmaceutical applications, Deloxolone is also being explored in the cosmetics industry. Its anti-inflammatory and antioxidant properties make it a candidate for skincare formulations aimed at reducing redness and irritation. This aligns with the growing consumer demand for science-backed, effective skincare ingredients. Searches for "Deloxolone in skincare" and "CAS 68635-50-7 benefits" have seen a notable increase, indicating public interest in its cosmetic potential.

The synthesis and production of Deloxolone involve advanced organic chemistry techniques. Researchers are continually optimizing its synthesis to improve yield and purity, which is critical for both pharmaceutical and industrial applications. The compound's stability under various conditions is another area of active investigation, as it impacts its shelf life and efficacy in different formulations.

Environmental and safety considerations are also paramount when discussing Deloxolone. Regulatory agencies worldwide are scrutinizing new compounds for their ecological impact, and Deloxolone is no exception. Studies on its biodegradability and toxicity profiles are ongoing, with preliminary data suggesting a favorable safety profile. This is particularly important given the increasing emphasis on sustainable and eco-friendly chemicals in both the pharmaceutical and cosmetic industries.

Another hot topic related to Deloxolone is its potential synergy with other bioactive compounds. Researchers are exploring combinations with natural extracts and other synthetic molecules to enhance its therapeutic effects. This approach, often referred to as combination therapy, is gaining traction as a way to address complex health issues with multifaceted mechanisms.

From a commercial perspective, the market for Deloxolone is expected to grow as more applications are validated. Pharmaceutical companies and cosmetic manufacturers are investing in research to capitalize on its unique properties. The compound's CAS registry number 68635-50-7 is often cited in patents and regulatory filings, underscoring its commercial viability.

In conclusion, Deloxolone (CAS No. 68635-50-7) represents a versatile compound with significant potential across multiple industries. Its anti-inflammatory and antioxidant properties make it a promising candidate for both therapeutic and cosmetic applications. As research progresses, the full scope of its benefits and applications will likely continue to expand, making it a compound to watch in the coming years.

• 303-43-5(Cholesteryl oleate)
• 1062-96-0(Cholesteryl hexanoate)
• 1183-04-6(Cholesteryl Decanoate)
• 604-33-1(Cholesterol Linoleate)
• 521-13-1(Cholesteryl N-Butyrate)
• 1182-42-9(Cholesterol Caprylate)
• 1908-11-8(Cholesterol Laurate)
• 1989-52-2(Cholesterol myristate)
• 1724-17-0(Methyl oleanolate)
• 633-31-8([(8S,9R,10R,13R,14S)-10,13-Dimethyl-17-(6-methylheptan-2-yl)-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] propanoate)